Drug intelligence / Profile preview

MSI1-C-terminus decoy peptide

Development stage
Preclinical
Lead developer
Taipei Veterans General Hospital
Modality
Peptides
Administration
Intratumoral
01

Overview

MSI1-C-terminus decoy peptide is a therapeutic peptide designed to disrupt the interaction between the RNA-binding protein Musashi1 (MSI1) and Argonaute2 (AGO2). In glioblastoma multiforme (GBM), MSI1 translocates to the cytoplasm under stress conditions and recruits AGO2 to form a complex that modulates mRNA stability, promoting tumor cell proliferation and survival. This decoy peptide mimics the C-terminal domain of MSI1, which is the site of direct binding to AGO2, thereby competitively inhibiting the formation of the MSI1/AGO2 complex. Preclinical studies in orthotopic mouse models of GBM have shown that delivery of this peptide effectively reduces stress-induced tumor progression, suggesting a novel peptide-based therapeutic strategy against refractory malignancies.

Other names
MSI1-C-terminus decoy peptidesMSI-1-C-terminus decoy peptidesMSI 1-C-terminus decoy peptides
02

Targets

AGO2 (Argonaute RISC catalytic component 2)MSI1 (RNA-binding protein Musashi homolog 1)

Beyond the preview

Go deeper on MSI1-C-terminus decoy peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MSI1-C-terminus decoy peptide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call